Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Told you so

<< Previous

Bullboard Posts

Next >>

Comment by sakinny3on Sep 10, 2021 4:09pm

153 Views

Post# 33841234

RE:Told you so

It must be very frustrating for Howard and team to be sitting there watching shareholders lose money when they know all that fantastic news but just can't tell us. I'm sure those that sold at a loss will understand, must be quite a few given how high the price was earlier in the year

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia